PIM
RAPT

Ponoi II Management’s RAPT Therapeutics RAPT Stock Holding History

Ponoi II Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.5M Hold
18,175
– – 9.14% 4
2022
Q2 		$2.65M Hold
18,175
– – 7.21% 4
2022
Q1 		$3.2M Hold
18,175
– – 7.09% 4
2021
Q4 		$5.34M Hold
18,175
– – 9.7% 4
2021
Q3 		$4.51M Hold
18,175
– – 6.69% 4
2021
Q2 		$4.62M Hold
18,175
– – 3.75% 5
2021
Q1 		$3.23M Hold
18,175
– – 2.47% 5
2020
Q4 		$2.87M Buy
+18,175
New +$3.95M 2.09% 5

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Ponoi II Management's RAPT Position: Q3 2022 in Review

Ponoi II Management held its RAPT Therapeutics (RAPT) position steady in Q3 2022 at 18,175 shares worth $3.5M. The position accounts for 9.14% of the portfolio, ranked #4.

Ponoi II Management first reported a position in RAPT in Q4 2020 and has held it in 8 quarters since. The position peaked at $5.34M in Q4 2021. 98 funds tracked by Wall St. Rank hold RAPT as of Q3 2022.

  • Ponoi II Management held 18,175 shares of RAPT Therapeutics worth $3.5M as of Q3 2022.
  • Ponoi II Management left its RAPT Therapeutics share count unchanged in Q3 2022.
  • RAPT Therapeutics made up 9.14% of Ponoi II Management's portfolio in Q3 2022, its #4 holding.
  • Ponoi II Management first reported a position in RAPT Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • Ponoi II Management's RAPT Therapeutics position peaked at $5.34M in Q4 2021.
  • 98 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2022.

Based on Ponoi II Management's 13F filing for Q3 2022, filed 14 Nov 2022.